AFFF Personal Injury Lawsuit Update: What Claimants Need to Know
Aqueous film-forming foam (AFFF) litigation has grown into one of the largest mass tort actions in recent U.S. legal history. Thousands of individuals — primarily military veterans, civilian firefighters, and airport workers — have filed personal injury claims alleging that exposure to AFFF caused serious illnesses, including several forms of cancer. Here's what the litigation looks like, how it has developed, and what shapes outcomes for individual claimants.
What Is AFFF and Why Is It the Subject of Litigation?
AFFF is a firefighting foam used for decades to suppress fuel-based fires. It contains per- and polyfluoroalkyl substances (PFAS) — a class of synthetic chemicals that do not break down easily in the environment or the human body. These chemicals are sometimes called "forever chemicals."
Scientific and regulatory attention has increasingly focused on PFAS compounds, particularly PFOA and PFOS, as potential carcinogens. The EPA has issued health advisories, and multiple studies have examined links between PFAS exposure and cancers including kidney cancer, testicular cancer, bladder cancer, thyroid cancer, and non-Hodgkin's lymphoma, among others.
Defendants in AFFF litigation have included major chemical manufacturers and suppliers. The core legal theory is that these companies knew or should have known about health risks associated with PFAS and failed to adequately warn users.
How AFFF Cases Are Being Handled: The MDL Structure
Most federal AFFF personal injury claims are consolidated in a multidistrict litigation (MDL) in the U.S. District Court for the District of South Carolina. MDLs are not class actions — each claimant retains an individual case. The MDL structure allows shared discovery and pretrial coordination while preserving individual fact-finding about exposure, diagnosis, and damages.
Bellwether trials — test cases selected to represent the broader pool of claims — are a central feature of MDL litigation. Results in bellwether trials often signal how defendants and plaintiffs may approach settlement negotiations across the larger case inventory.
Some AFFF cases have also been filed in state courts, which operate under different procedural rules and timelines than the federal MDL.
Settlement Developments and What They Mean
Several significant settlement agreements have emerged from AFFF litigation:
- 3M Company announced a settlement agreement valued at approximately $10–12 billion to resolve water contamination claims brought by public water systems. This settlement addressed municipal claims, not personal injury claims.
- DuPont, Chemours, and Corteva reached separate agreements addressing water utility claims.
- Personal injury claims — those brought by individuals alleging cancer or other illness — have followed a different and generally slower track than the water utility settlements.
⚖️ The distinction matters: water system claims and personal injury claims involve different defendants, different theories of harm, and different settlement pools. A settlement resolving municipal water contamination does not automatically resolve or fund individual cancer claims.
As of recent court activity, personal injury bellwether trials in the federal MDL have been scheduled and rescheduled multiple times. Litigation timelines in large MDLs are frequently affected by discovery disputes, appeals, defendant negotiations, and judicial case management decisions.
What Individual Claimants Must Generally Establish
Regardless of broader MDL developments, each personal injury claimant typically needs to demonstrate:
| Element | What It Generally Involves |
|---|---|
| Exposure | Contact with AFFF at a specific location and duration |
| Causation | A scientific or medical link between that exposure and the diagnosed condition |
| Diagnosis | A qualifying illness, typically a specific cancer type |
| Damages | Medical costs, lost income, pain and suffering, and related losses |
General causation — whether PFAS can cause a particular disease — is often litigated at the MDL level. Specific causation — whether this claimant's illness was caused by their particular exposure — is evaluated case by case and typically requires expert medical testimony.
Variables That Shape Individual Outcomes
No two AFFF claims are identical. Outcomes depend heavily on:
- Type and severity of illness — different cancers carry different prognoses, treatment costs, and damages profiles
- Exposure history — duration, location, and role (military, municipal firefighter, industrial facility)
- State of filing — state courts and the federal MDL operate under different rules; statutes of limitations vary by state and may be affected by when a claimant knew or should have known about the connection between exposure and illness
- Which defendants are named — manufacturer involvement, corporate successor liability, and which entities remain solvent affect recovery potential
- Litigation posture at the time of filing — where the MDL stands, whether bellwether verdicts have occurred, and whether global settlement discussions are active all influence how cases move
🔬 Scientific and regulatory developments also affect litigation in real time. New EPA standards, emerging epidemiological studies, and agency rulings can shift how courts and parties evaluate causation arguments.
How Attorneys Typically Get Involved
AFFF personal injury claims are almost universally handled by attorneys on a contingency fee basis, meaning the attorney is paid a percentage of any recovery rather than charging upfront fees. In mass tort MDLs, attorney fees may also be subject to common benefit assessments — a portion set aside to compensate attorneys who did shared work benefiting all claimants.
Because these cases require specialized scientific and medical expertise, most claimants work with attorneys who focus specifically on toxic tort or mass tort litigation.
The Gap That Remains
📋 AFFF litigation is actively evolving. Settlement structures, trial schedules, and bellwether outcomes continue to shift. Whether a particular claimant's illness qualifies, which defendants may be liable, what damages may be recoverable, and what deadlines apply all depend on that person's specific exposure history, diagnosis, state of residence, and the current posture of the litigation at the time they seek to file.
What applies to one claimant in one state with one diagnosis may not apply to another. The general framework described here explains how the litigation works — the specific facts of any individual situation determine where within that framework a claim actually falls.
